NA Pharmacogenetic Testing Market - Industry Trends and Forecast to 2034

Best Price Guarantee	Length	Publisher	Published Date	SKU
from $3,500	173 Pages	Data Bridge Market Research	October, 2023	DAABD18360507

Best Price Guarantee
Price	from $3,500
Length	173 Pages
Publisher	Data Bridge Market Research
Published Date	October, 2023
SKU	DAABD18360507

NA Pharmacogenetic Testing Market - Industry Trends and Forecast to 2034

The North America pharmacogenetic testing market is expected to reach USD 5,318.02 million by 2030 from USD 2,723.12 million in 2022, growing at a CAGR of 8.9% during the forecast period of 2023 to 2030.

Market Segmentation
North America Pharmacogenetic Testing Market, By Type (Whole Genome Sequencing, Whole Exome Sequencing, Array-Based Tests, and Single Gene Tests), Gene Type (CYP2C19, CYP2D6, CYP2C9 AND VKORC1, CYP1A2, HLA-B*1502, HLA-B*5701, CYP2D, OPRM1, ONCOTYPE DX AND MAMMAPRINT, DRD3, D4D4, SLC6A4, HTR2A/C, TMPT, and Others), Drug Type (Prescription Drugs, Nutraceuticals, Recreational Drugs, Herbal Supplements, Vitamins, and Over-the-Counter Medications), Sample (Blood and Saliva), Therapeutic Area (Cardiology, Gastroenterology, Anesthesiology, Genomics, Endocrinology, Immunology & Hypersensitivity, Dermatology, Gynecology, Oncology, Neurology, and Others), Application (Clinical Practice, Drug Development, and Drug Regulation), End User (Healthcare Providers, Pharmaceutical & Biotechnology Companies, Research Centres and Academic Institutes, and Others), Distribution Channel (Hospital Pharmacy, Retail Pharmacies, Mail-Order Pharmacies, and Direct-to-Customer Services), Country (U.S., Canada, and Mexico) - Industry Trends and Forecast to 2030

Overview of Global Pharmacogenetic Testing Market Dynamics

Driver
• Rapid technological advancement and miniaturization
Restrain

• Environment and health concerns
Opportunity

• Rising research and development and innovative technologies

Market Players

Some of the major market players operating in the North America pharmacogenetic testing market are:

• Thermo Fisher Scientific
• Illumina, Inc
• QIAGEN
• Sonic Healthcare
• BGI

1 Introduction: 1.1 Objectives Of The Study; 1.2 Market Definition; 1.3 Overview Of North America Pharmacogenetic Testing Market; 1.4 Currency And Pricing; 1.5 Limitations; 1.6 Markets Covered
2 Market Segmentation: 2.1 Markets Covered; 2.2 Geographical Scope; 2.3 Years Considered For The Study; 2.4 Dbmr Tripod Data Validation Model; 2.5 Primary Interviews With Key Opinion Leaders; 2.6 Dbmr Market Position Grid; 2.7 Multivariate Modelling; 2.8 Type Lifeline Curve; 2.9 Market End User Coverage Grid; 2.10 Secondary Sources; 2.11 Assumptions
3 Executive Summary
4 Premium Insights: 4.1 Pestel Analysis; 4.2 Porter’sfive Forces; 4.3 Industry Insights And Strategic Analysis
5 Market Overview: 5.1 Drivers; 5.1.1 Increasing Adoption Of Personalized Medicine; 5.1.2 Advancements In Genomic Technologies; 5.1.3 Increasing Chronic And Complex Diseases; 5.1.4 Role Of Pharmacogenetic Testing In Drug Discovery And Development; 5.2 Restraints; 5.2.1 Dependency On The Medical And Genomic Expert For Result Interpretation; 5.2.2 Ethical And Privacy Concerns Associated With Pharmacogenetic Testing 49; 5.3 Opportunities; 5.3.1 Integration With Electronic Health Records (Ehrs); 5.3.2 Artificial Intelligence (Ai) And Machine Learning Integration In Healthcare; 5.4 Challenges; 5.4.1 Challenges In Clinical Implementation Of Pharmacogenetics; 5.4.2 Complexity Associated With Pharmacogenetic Testing Results
6 North America Pharmacogenetic Testing Market, By Type: 6.1 Overview; 6.2 Whole Genome Sequencing; 6.2.1 Next Generation Sequencing (Ngs); 6.2.2 Sanger Sequencing; 6.3 Whole Exome Sequencing; 6.3.1 Next Generation Sequencing (Ngs); 6.3.2 Sanger Sequencing; 6.4 Array-based Tests; 6.4.1 Glass Slide Arrays; 6.4.2 In—situ Synthesized Arrays; 6.4.3 Self Assembled Arrays; 6.5 Single Gene Tests; 6.5.1 Next Generation Sequencing (Ngs); 6.5.2 Sanger Sequencing
7 North America Pharmacogenetic Testing Market, By Gene Type: 7.1 Overview; 7.2 Cyp2c19; 7.3 Cyp2d6; 7.4 Cyp2c9 And Vkorc1; 7.5 Cyp1a2; 7.6 Hla-b*1502; 7.7 Hla-b*5701; 7.8 Cyp2d; 7.9 Oprm1; 7.10 Oncotype Dx* And Mammaprint; 7.11 Drd3; 7.12 D4d4; 7.13 Slc6a4; 7.14 Htr2a/C; 7.15 Tmpt; 7.16 Others
8 North America Pharmacogenetic Testing Market, By Drug Type: 8.1 Overview; 8.2 Prescription Drugs; 8.3 Nutraceuticals; 8.4 Recreational Drugs; 8.5 Herbal Supplements; 8.6 Vitamins; 8.7 Over-the-counter Medications
9 North America Pharmacogenetic Testing Market, By Sample: 9.1 Overview; 9.2 Blood; 9.3 Saliva
10 North America Pharmacogenetic Testing Market, By Therapeutic Area: 10.1 Overview; 10.2 Cardiology; 10.3 Gastroenterology; 10.4 Anesthesiology; 10.5 Genomics; 10.6 Endocrinology; 10.7 Immunology & Hypersensitivity; 10.8 Dermatology; 10.9 Gynecology; 10.10 Oncology; 10.11 Neurology; 10.12 Others
11 North America Pharmacogenetic Testing Market, By Application: 11.1 Overview; 11.2 Clinical Practice; 11.2.1 Side Effects; 11.2.2 Drug Effectiveness; 11.2.3 Dosage; 11.3 Drug Development; 11.3.1 Drug Effectiveness; 11.3.2 Dosage; 11.3.3 Side Effects 100; 11.4 Drug Regulation; 11.4.1 Side Effects; 11.4.2 Drug Effectiveness; 11.4.3 Dosage
12 North America Pharmacogenetic Testing Market, By End User: 12.1 Overview; 12.2 Healthcare Providers; 12.3 Pharmaceutical & Biotechnology Companies; 12.4 Research Centres And Academic Institutes; 12.5 Others
13 North America Pharmacogenetic Testing Market, By Distribution Channel: 13.1 Overview; 13.2 Hospital Pharmacy; 13.3 Retail Pharmacies; 13.4 Mail-order Pharmacies; 13.5 Direct-to-customer Services
14 North America Pharmacogenetic Testing Market, By Region: 14.1 North America
15 North America Pharmacogenetic Testing Market: Company Landscape: 15.1 Company Share Analysis: North America
16 Swot Analysis
17 Company Profile: 17.1 Thermo Fisher Scientific Inc.; 17.1.1 Company Snapshot; 17.1.2 Revenue Analysis; 17.1.3 Company Share Analysis; 17.1.4 Product Portfolio; 17.1.5 Recent Developments; 17.2 Illumina, Inc.; 17.2.1 Company Snapshot; 17.2.2 Revenue Analysis; 17.2.3 Company Share Analysis; 17.2.4 Product Portfolio; 17.2.5 Recent Development 144; 17.3 Qiagen; 17.3.1 Company Snapshot; 17.3.2 Revenue Analysis; 17.3.3 Company Share Analysis; 17.3.4 Product Portfolio; 17.3.5 Recent Development; 17.4 Sonic Healthcare; 17.4.1 Company Snapshot; 17.4.2 Revenue Analysis; 17.4.3 Company Share Analysis; 17.4.4 Product Portfolio; 17.4.5 Recent Development; 17.5 Bgi; 17.5.1 Company Snapshot; 17.5.2 Company Share Analysis; 17.5.3 Product Portfolio; 17.5.4 Recent Development; 17.6 23andme, Inc; 17.6.1 Company Snapshot; 17.6.2 Revenue Analysis; 17.6.3 Product Portfolio; 17.6.4 Recent Development; 17.7 Dynamic Dna Laboratories; 17.7.1 Company Snapshot; 17.7.2 Product Portfolio; 17.7.3 Recent Development; 17.8 Eurofins Scientific (2022); 17.8.1 Company Snapshot; 17.8.2 Revenue Analysis; 17.8.3 Product Portfolio; 17.8.4 Recent Development; 17.9 Genewix (A Subsidiary Of Azenta Life Science); 17.9.1 Company Snapshot; 17.9.2 Product Portfolio; 17.9.3 Recent Development; 17.10 Luminex Corporation (A Subsidiary Of Diasorin); 17.10.1 Company Snapshot; 17.10.2 Product Portfolio; 17.10.3 Recent Development; 17.11 Md Labs; 17.11.1 Company Snapshot; 17.11.2 Product Portfolio; 17.11.3 Recent Development; 17.12 Myriad Genetics, Inc.; 17.12.1 Company Snapshot; 17.12.2 Revenue Analysis; 17.12.3 Product Portfolio; 17.12.4 Recent Developments; 17.13 Oneome; 17.13.1 Company Snapshot; 17.13.2 Product Portfolio; 17.13.3 Recent Development; 17.14 Pacbio; 17.14.1 Company Snapshot; 17.14.2 Revenue Analysis; 17.14.3 Product Portfolio; 17.14.4 Recent Development; 17.15 Perkinelmer Inc.; 17.15.1 Company Snapshot; 17.15.2 Revenue Analysis; 17.15.3 Product Portfolio; 17.15.4 Recent Development; 17.16 Pgxt; 17.16.1 Company Snapshot; 17.16.2 Product Portfolio; 17.16.3 Recent Development
18 Questionnaire
19 Related Reports
List Of Tables: Table 1 North America Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 2 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 3 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 4 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 5 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 6 North America Array-based Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 7 North America Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 8 North America Single Gene Tests In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 9 North America Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 10 North America Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 11 North America Cyp2c19 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 12 North America Cyp2d6 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 13 North America Cyp2c9 And Vkorc1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 14 North America Cyp1a2 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 15 North America Hla-b*1502 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 16 North America Hla-b*5701 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 17 North America Cyp2d In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 18 North America Oprm1 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 19 North America Oncotype Dx* And Mammaprint In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 20 North America Drd3 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 21 North America D4d4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 22 North America Slc6a4 In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 23 North America Htr2a/C In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 24 North America Tmpt In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 25 North America Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 26 North America Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 27 North America Prescription Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 28 North America Nutraceuticals In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 29 North America Recreational Drugs In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 30 North America Herbal Supplements In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 31 North America Vitamins In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 32 North America Over-the-counter Medications In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 33 North America Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 34 North America Blood In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 35 North America Saliva In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 36 North America Pharmacogenetic Testing Market, By Therpaeutic Area, 2021-2030 (Usd Million); Table 37 North America Cardiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 38 North America Gastroenterology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 39 North America Anesthesiology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 40 North America Genomics In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 41 North America Endocrinology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 42 North America Immunology & Hypersensitivity In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 43 North America Dermatology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 44 North America Gynecology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 45 North America Oncology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 46 North America Neurology In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 47 North America Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 48 North America Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 49 North America Clinical Practice In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 50 North America Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 51 North America Drug Development In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 52 North America Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 53 North America Drug Regulation In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 54 North America Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 55 North America Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 56 North America Healthcare Providers In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 57 North America Pharmaceutical & Biotechnology Companies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 58 North America Research Centres And Academic Institutes In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 59 North America Others In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 60 North America Pharmacogenetic Testing Market, By Distribution Channel, 2020-2030 (Usd Million); Table 61 North America Hospital Pharmacy In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 62 North America Retail Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 63 North America Mail-order Pharmacies In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 64 North America Direct-to-customer Services In Pharmacogenetic Testing Market, By Region, 2021-2030 (Usd Million); Table 65 North America Pharmacogenetic Testing Market, By Country, 2021-2030 (Usd Million); Table 66 North America Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 67 North America Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 68 North America Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 69 North America Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 70 North America Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 71 North America Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 72 North America Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 73 North America Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 74 North America Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 75 North America Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 76 North America Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 77 North America Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 78 North America Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 79 North America Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 80 North America Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 81 U.S. Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 82 U.S. Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 83 U.S. Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 84 U.S. Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 85 U.S. Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 86 U.S. Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 87 U.S. Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 88 U.S. Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 89 U.S. Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 90 U.S. Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 91 U.S. Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 92 U.S. Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 93 U.S. Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 94 U.S. Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 95 U.S. Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 96 Canada Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 97 Canada Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 98 Canada Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 99 Canada Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 100 Canada Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 101 Canada Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 102 Canada Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 103 Canada Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 104 Canada Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 105 Canada Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 106 Canada Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 107 Canada Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 108 Canada Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 109 Canada Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 110 Canada Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million); Table 111 Mexico Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 112 Mexico Whole Genome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 113 Mexico Whole Exome Sequencing In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 114 Mexico Array-based Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 115 Mexico Single Gene Tests In Pharmacogenetic Testing Market, By Type, 2021-2030 (Usd Million); Table 116 Mexico Pharmacogenetic Testing Market, By Gene Type, 2021-2030 (Usd Million); Table 117 Mexico Pharmacogenetic Testing Market, By Drug Type, 2021-2030 (Usd Million); Table 118 Mexico Pharmacogenetic Testing Market, By Sample, 2021-2030 (Usd Million); Table 119 Mexico Pharmacogenetic Testing Market, By Therapeutic Area, 2021-2030 (Usd Million); Table 120 Mexico Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 121 Mexico Clinical Practice In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 122 Mexico Drug Development In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 123 Mexico Drug Regulation In Pharmacogenetic Testing Market, By Application, 2021-2030 (Usd Million); Table 124 Mexico Pharmacogenetic Testing Market, By End User, 2021-2030 (Usd Million); Table 125 Mexico Pharmacogenetic Testing Market, By Distribution Channel, 2021-2030 (Usd Million)
List Of Figures: Figure 1 North America Pharmacogenetic Testing Market: Segmentation; Figure 2 North America Pharmacogenetic Testing Market: Data Triangulation; Figure 3 North America Pharmacogenetic Testing Market: Droc Analysis; Figure 4 North America Pharmacogenetic Testing Market: North America Vs Regional Market Analysis; Figure 5 North America Pharmacogenetic Testing Market: Company Research Analysis; Figure 6 North America Pharmacogenetic Testing Market: Interview Demographics; Figure 7 North America Pharmacogenetic Testing Market: Dbmr Market Position Grid; Figure 8 North America Pharmacogenetic Testing Market: Market End User Coverage Grid; Figure 9 North America Pharmacogenetic Testing Market: Segmentation; Figure 10 Increasing Adoption Of Personalized Medicine Is Driving The Growth Of The North America Pharmacogenetic Testing Market In The Forecast Period Of 2023 To 2030; Figure 11 Whole Genome Sequencing Segment Is Expected To Account For The Largest Share Of The North America Pharmacogenetic Testing Market In 2023 & 2030; Figure 12 Drivers, Restraints, Opportunities, And Challenges Of North America Pharmacogenetic Testing Market; Figure 13 North America Pharmacogenetic Testing Market: By Type, 2022; Figure 14 North America Pharmacogenetic Testing Market: By Type, 2023-2030 (Usd Million); Figure 15 North America Pharmacogenetic Testing Market: By Type, Cagr (2023-2030); Figure 16 North America Pharmacogenetic Testing Market: By Type, Lifeline Curve; Figure 17 North America Pharmacogenetic Testing Market: By Gene Type, 2022; Figure 18 North America Pharmacogenetic Testing Market: By Gene Type, 2023-2030 (Usd Million); Figure 19 North America Pharmacogenetic Testing Market: By Gene Type, Cagr (2023-2030); Figure 20 North America Pharmacogenetic Testing Market: By Gene Type, Lifeline Curve; Figure 21 North America Pharmacogenetic Testing Market: By Drug Type, 2022; Figure 22 North America Pharmacogenetic Testing Market: By Drug Type, 2023-2030 (Usd Million); Figure 23 North America Pharmacogenetic Testing Market: By Drug Type, Cagr (2023-2030); Figure 24 North America Pharmacogenetic Testing Market: By Drug Type, Lifeline Curve; Figure 25 North America Pharmacogenetic Testing Market: By Sample, 2022; Figure 26 North America Pharmacogenetic Testing Market: By Sample, 2023-2030 (Usd Million); Figure 27 North America Pharmacogenetic Testing Market: By Sample, Cagr (2023-2030); Figure 28 North America Pharmacogenetic Testing Market: By Sample, Lifeline Curve; Figure 29 North America Pharmacogenetic Testing Market: By Therapeutic Area, 2022; Figure 30 North America Pharmacogenetic Testing Market: By Therapeutic Area, 2023-2030 (Usd Million); Figure 31 North America Pharmacogenetic Testing Market: By Therapeutic Area, Cagr (2023-2030); Figure 32 North America Pharmacogenetic Testing Market: By Therapeutic Area, Lifeline Curve; Figure 33 North America Pharmacogenetic Testing Market: By Application, 2022; Figure 34 North America Pharmacogenetic Testing Market: By Application, 2023-2030 (Usd Million); Figure 35 North America Pharmacogenetic Testing Market: By Application, Cagr (2023-2030); Figure 36 North America Pharmacogenetic Testing Market: By Application, Lifeline Curve; Figure 37 North America Pharmacogenetic Testing Market: By End User, 2022; Figure 38 North America Pharmacogenetic Testing Market: By End User, 2023-2030 (Usd Million); Figure 39 North America Pharmacogenetic Testing Market: By End User, Cagr (2023-2030); Figure 40 North America Pharmacogenetic Testing Market: By End User, Lifeline Curve; Figure 41 North America Pharmacogenetic Testing Market: By Distribution Channel, 2022; Figure 42 North America Pharmacogenetic Testing Market: By Distribution Channel, 2023-2030 (Usd Million); Figure 43 North America Pharmacogenetic Testing Market: By Distribution Channel, Cagr (2023-2030); Figure 44 North America Pharmacogenetic Testing Market: By Distribution Channel, Lifeline Curve; Figure 45 North America Pharmacogenetic Testing Market: Snapshot (2022); Figure 46 North America Pharmacogenetic Testing Market: Company Share 2022 (%)